PepGen (PEPG) EBITDA (2021 - 2026)

PepGen (PEPG) has 6 years of EBITDA data on file, last reported at -$18.9 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA rose 39.52% year-over-year to -$18.9 million; the trailing twelve-month figure through Mar 2026 stood at -$81.2 million (up 25.65% YoY), and the FY2025 full-year result was -$93.6 million, up 4.22% from the prior year.
• EBITDA advanced to -$18.9 million in Q1 2026, from -$19.7 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of -$13.9 million in Q1 2022 to a low of -$31.3 million in Q1 2025.
• A 5-year average of -$21.4 million and a median of -$19.8 million in 2024 frame the typical range for EBITDA.
• Across the five-year window, EBITDA sank 239.77% in 2022 and soared 39.52% in 2026, its largest moves.
• Tracing PEPG's EBITDA over 5 years: stood at -$17.2 million in 2022, then dropped by 20.9% to -$20.8 million in 2023, then retreated by 16.98% to -$24.3 million in 2024, then climbed by 19.06% to -$19.7 million in 2025, then climbed by 3.87% to -$18.9 million in 2026.
• Business Quant data shows PEPG's EBITDA at -$18.9 million in Q1 2026, -$19.7 million in Q4 2025, and -$18.7 million in Q3 2025.